Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase

Biotechnic and Histochemistry

Volumn 73, Issue 6, 1998, Pages 316-324

  Janckila, Anthony J ^a,b   Walton, Stephanie P ^b   Yam, Lung T ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Hairy cell; Immunoassay; Immunohistochemistry; Macrophage; Monoclonal antibodies; Osteoclast; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14G6; MONOCLONAL ANTIBODY 9C5; TARTARIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ELECTROPHORESIS; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; SPECIES DIFFERENCE;

ANIMALIA; RODENTIA;

EID: 0032422863     PISSN: 10520295     EISSN: None     Source Type: Journal    
DOI: 10.3109/10520299809141125     Document Type: Article

References (42)

1. Alvarez, L., Guanabens, N., Peris, P., Monegal, A., Bedini, J. L., Deulofeu, R., Martinez de Osaba, M. J., Munoz-Gomez, J., Rivera-Fillat, F. and Ballesta, A. M. 1995. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J. Bone Miner. Res. 10: 458-465.
2. Anderson, T. S. and Toverud, S. U. 1986. Purification and characterization of purple acid phosphatase from developing rat bone. Arch. Biochem. Biophys. 247: 131-139.
3. Baumbach, G. A., Saunders, P. T. K., Bazer, F. W. and Roberts, R. M. 1984. Uteroferrin has N-asparagine-linked high-mannose-type oligosaccharides that contain mannose 6-phosphate. Proc. Natl. Acad. Sci. USA. 81: 2985-2989.
4. Baumbach, G. A., Saunders, P. T. K., Ketcham, C. M., Bazer, F. W. and Roberts, R. M. 1991. Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro. Mol. Cell. Biochem. 105: 107-117.
5. Bikle D. D. 1997. Biochemical markers in the assessment of bone disease. Am. J. Med. 103:427-436.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of micrograms quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
7. Campbell, H. D., Dionysius, D. A., Keough, D. T., Wilson, B. E., de Jersey, J. and Zerner, B. 1978. Iron-containing acid phosphatase: comparison of the enzymes from beef spleen and pig allantoic fluid. Biochem. Biophys. Res. Commun. 82: 615-620.
8. Chamberlain, P., Comptston, J., Cox, T. M., Hayman, A. R., Imrie, R. C., Reynolds, K. and Holmes, S. D. 1995. Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum. Clin. Chem. 41: 1495-1499.
9. Chen, J., Yam, L. T., Janckila, A. J., Li, C.-Y. and Lam, K. W. 1979. Significance of "high" serum acid phosphatase activity in normal children. Clin. Chem. 25: 719-722.
10. Cheung, C. K., Panesar, N. S., Haines, C., Masarei, J. and Swaminathan, R. 1995. Immunoassay of a tartrate-resistant acid phosphatase in serum. Clin. Chem. 41: 679-686.
11. Cummings, S. R. Kelsey, J. L., Nevitt, M. C. and O'Dowd, K. J. 1985. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol. Rev. 7: 178-208.
12. Echetebu, Z. O., Cox, T. M. and Moss, D. W. 1987. Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase. Clin. Chem. 33: 1832-1836.
13. Ek-Rylander, B., Bergman, T. and Andersson, G. 1991. Characterization of a tartrate-resistant acid phosphatase (ATPase) from rat bone: hydrodynamic properties and N-terminal amino acid sequence. J. Bone Miner. Res. 6: 365-373.
14. Ek-Rylander, B., Barkhem, T., Ljusberg, J., Ohman, L., Andersson, K. K. and Andersson, G. 1997. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. Biochem. J. 321: 305-311.
15. Gavilanes, E. L., Parra, E. G., de la Piedra, C., Caramelo, C. and Rapado, A. 1994. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure. Miner. Electrolyte Metab. 20: 259-264.
16. Halleen, J., Hentunen, T. A., Hellman, J. and Vaanenen, H. K. 1996. Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay. J. Bone Miner. Res. 11: 1444-1452.
17. Hayman, A. R., Warburton, M. J., Pringle, J. A. S., Coles, B. and Chambers, T. J. 1989. Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas. Biochem. J. 261: 601-609.
18. Hayman, A. R. and Cox, T. M. 1994. Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J. Biol. Chem. 269: 1294-1300.
19. Janckila, A. J., Latham, M. D., Lam, K. W., Chow, K. C., Li, C.-Y. and Yam, L. T. 1992. Heterogeneity of hairy cell tartrate-resistant acid phosphatase. Clin. Biochem. 25: 437-243.
20. Janckila, A. J., Cardwell, E. M., Yam, L. T. and Li, C.-Y. 1995 Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase. Blood 85: 2839-2844.
21. Janckila, A. J., Lear, S. C., Martin, A. W. and Yam, L. T. 1996. Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase. J. Histochem. Cytochem. 44: 235-244.
22. Janckila, A. J., Cardwell, E. M. and Yam, L. T. 1997. Characterization of monoclonal antibodies specific to human tartrate-resistant acid phosphatase. Hybridoma 16: 175-182.
23. Ketcham, C. M., Baumbach, G. A., Bazer, F. W. and Roberts, R. M. 1985. The type-5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin. J. Biol. Chem. 260: 5768-5776.
24. Kraenzlin, M. E., Lau, K. H. W., Liang, L., Freeman, T. K., Singer, F. R., Stepan, J. and Baylink, D. J. 1990. Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. J. Clin. Endocrinol. Metab. 71: 442-451.
25. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-285.
26. Lam, K. W., Siemens, M., Sun, T., Li, C.-Y. and Yam, L. T. 1982. Enzyme immunoassay for tartrate-resistant acid phosphatase. Clin. Chem. 28: 467-270.
27. Lau, K.-H. W., Onishi, T., Wergedal, J. E., Singer, F. R. and Baylink, D. J. 1987. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin. Chem. 33: 458-462.
28. Li, C.-Y., Yam, L. T. and Lam, K. W. 1970. Studies on acid phosphatase isoenzymes of human leukocytes. Demonstration of isoenzyme-cell specificity. J. Histochem. Cytochem. 18: 901-910.
29. Marshall, K., Nash, K., Haussman, G., Cassady, I., Hume, D., deJersey, J. and Hamilton, S. 1997 Recombinant human and mouse purple acid phosphatases: expression and characterization. Arch. Biochem. Biophys. 345: 230-236.
30. McGadey, J. 1970. A tetrazolium method for non-specific alkaline phosphatase. Histochemie 23: 180-184.
31. Miller, S. 1997. Models of skeletal osteopenia in the rat. J. Histotechnol. 20: 209-13.
32. Moscovici, A., Bernheim, J., Popovtzer, M. M. and Rubinger, D. 1996. Renal osteodystrophy in rats with reduced renal mass. Nephrol. Dial. Transplant. 11(Suppl. 3): 146-152.
33. Movsowitz, C., Epstein, S., Fallon, M., Ismail, F. and Thomas, S. 1988. Cyclosporin-A in vivo produces severe osteopenia in rat: effect of dose and duration of administration. Endocrinology 123: 2571-2577.
34. Orlando, J. L., Zirino, T., Quirk, B. J. and Averill, B. A. 1993. Purification and properties of the native form of the purple acid phosphatase from bovine spleen. Biochemistry 32: 8120-8129.
35. Risteli, L. and Risteli, J. 1993. Biochemical markers of bone metabolism. Ann. Med. 25: 385-393.
36. Robinson, D. B. and Glew, R. H. 1980. A tartrate-resistant acid phosphatase from Gaucher spleen. J. Biol. Chem. 255: 5864-5870.
37. Seibel, M. J., Cosman, F., Shen, V., Gordon, S., Dempster, D. W., Ratcliffe, A. and Lindsay, R. 1993. Urinary hydroxypyridinium crosslinks on collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J. Bone. Miner. Res. 8: 881-889.
38. Suda, T., Nakamura, I., Jimi, E. and Takahashi, N. 1997. Regulation of osteoclast function. J. Bone Miner. Res. 12: 869-879.
39. Tavassoli, M. and Yelenosky, R. 1977. Platelet-derived acid phosphatase isoenzyme in the serum in thrombocythemia. Am. J. Clin. Pathol. 67: 177-179.
40. Tavassoli, M., Rizo, M. and Yam, L. T. 1980. Elevation of serum acid phosphatase in cancers with bone metastasis. Cancer 45: 2400-2403.
41. Yam, L. T., Janckila, A. J., Lam, K. W. and Li, C.-Y. 1987. Cytochemistry of tartrate-resistant acid phosphatase. 15 Years' experience. Leukemia 1: 285-288.
42. Yaziji, H., Janckila, A. J., Lear, S. C., Martin, A. W. and Yam, L. T. 1995. Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hemopoietic human tissues. Am. J. Clin. Pathol. 104: 397-402.